Sentences with phrase «levels in a number of other countries»

These declines are occurring at a time when literacy levels in a number of other countries are improving and when Australia requires a more literate citizenry.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The assay was implemented in five countries and tested using a large number of clinical samples from travelers and patients living in areas with a high level of exposure to Zika virus and other flaviviruses.

(09/11/2013) Eight Indonesian villagers have sued the country's president and a number of other high - level government officials over the impacts of climate change and environmental destruction in their province, reports Mongabay - Indonesia.

This technical document provides the following information: - An update of global greenhouse gas emission estimates, based on a number of different authoritative scientific sources; - An overview of national emission levels, both current (2010) and projected (2020) consistent with current pledges and other commitments; - An estimate of the level of global emissions consistent with the two degree target in 2020, 2030 and 2050; - An update of the assessment of the «emissions gap» for 2020; - A review of selected examples of the rapid progress being made in different parts of the world to implement policies already leading to substantial emission reductions and how they can be scaled up and replicated in other countries, with the view to bridging the emissions gap.

China is now generating electricity using coal fuel at record high levels and in addition is engaging in efforts with other countries such as Pakistan to build large numbers of coal plants in that country.

A higher than usual level of amplitude modulation has been reported to occur for brief periods at a small number of wind farm sites in other countries.

It reveals that a number of factors influence the process and likelihood of convergence between the two, including knowledge of English or French, level and country of education, recognition of foreign credentials, and presence of social networks in Canada, among others.